Parallel Advisors »

Miragen Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $637 28 22.75

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Amazon.com Stock (AMZN)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Vanguard Total Stk Mkt Etf (VTI)
Costco Wholesale Corp Stock (COST)

View all positions for Parallel Advisors

Top funds holding Miragen Therapeutics

BlackRock
BlackRock
Deep Track Capital
VR Adviser
Fairmount Funds Management
Vanguard Group
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
Commodore Capital
Novo A/S
Tang Capital Management
Alliancebernstein
Maverick Capital
Driehaus Capital Management

View all funds holding Miragen Therapeutics